4. Additional maintenance asthma controller medications that are locally approved in a country for the treatment of asthma (eg, leukotriene receptor antagonists (LTRAs), tiotropium, chromone, theophylline, oral corticosteroid), and have been used for at least 30 days prior to Visit 1 are allowed.